Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18]BCPP-EF and [F-18]FDG PET Imaging in Alcohol Use Disorder
NCT07825818Phase 1Recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2032
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]BCPP-EF in alcohol use disorder (AUD). Primary endpoints: Dorsolateral prefrontal cortex [F-18]BCPP-EF Volume of Distribution (VT) at 0 weeks, Orbitofrontal cortex [F-18]BCPP-EF Volume of Distribution (VT) at 0 weeks and 4 more. Started Sep 2026; status: recruiting.
02
Drugs
[18F]BCPP-EF
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07825818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825818.